Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted By: MarketWatch November 20, 2023 at 06:33 AM EST Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for the anti-thrombotic drug asundexian due to a lack of efficacy. Read More >> Related Stocks: Bristol-Myers Squibb Pfizer Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted By: MarketWatch November 20, 2023 at 06:33 AM EST Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for the anti-thrombotic drug asundexian due to a lack of efficacy. Read More >> Related Stocks: Bristol-Myers Squibb Pfizer